Dark Streaming/Mobile Old Site Home Daily Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
17:22:11 EST Tue 28 Nov 2023
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

News for C:MDNA from 2022-11-29 to 2023-11-28 - 35 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2023-11-17 11:15C:MDNAMedicenna Therapeutics Corp0.44News ReleaseMedicenna talks survival benefit in bizaxofusp trial
2023-11-14 14:43C:MDNAMedicenna Therapeutics Corp0.53News ReleaseMedicenna Therapeutics' Sept. 30 cash at $25.7-million
2023-11-14 08:42C:MDNAMedicenna Therapeutics Corp0.53SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-14 08:38C:MDNAMedicenna Therapeutics Corp0.53SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-06 10:03C:MDNAMedicenna Therapeutics Corp0.435News ReleaseMedicenna presents phase 1 MDNA11 study data at SITC
2023-11-03 12:07C:MDNAMedicenna Therapeutics Corp0.25News ReleaseMedicenna details preclinical MDNA113 data at SITC
2023-10-27 10:05C:MDNAMedicenna Therapeutics Corp0.335News ReleaseMedicenna receives Nasdaq delisting notice
2023-10-25 09:48C:MDNAMedicenna Therapeutics Corp0.36News ReleaseMedicenna doses first patient in Ability dose expansion
2023-10-10 13:17C:MDNAMedicenna Therapeutics Corp0.39News ReleaseMedicenna appoints Gardner chief medical officer
2023-10-03 09:57C:MDNAMedicenna Therapeutics Corp0.385News ReleaseMedicenna details preclinical MDNA223 data at AACR
2023-09-28 17:21C:MDNAMedicenna Therapeutics Corp0.38News ReleaseMedicenna shareholders elect five directors at AGM
2023-08-28 11:25C:MDNAMedicenna Therapeutics Corp0.51News ReleaseMedicenna Therapeutics appoints Caravella as CFO
2023-08-14 10:55C:MDNAMedicenna Therapeutics Corp0.50News ReleaseMedicenna appoints Meadows as chief business officer
2023-08-09 10:40C:MDNAMedicenna Therapeutics Corp0.56News ReleaseMedicenna begins Ability monotherapy dose expansion
2023-08-08 12:31C:MDNAMedicenna Therapeutics Corp0.56News ReleaseMedicenna appoints Yavari as advisory committee chair
2023-08-04 12:04C:MDNAMedicenna Therapeutics Corp0.50News ReleaseMedicenna to hold Ability study update call Aug. 9
2023-08-01 12:40C:MDNAMedicenna Therapeutics Corp0.62News ReleaseMedicenna receives U.S. patent for IL-2 superkines
2023-07-28 10:35C:MDNAMedicenna Therapeutics Corp0.58News ReleaseMedicenna spends $2.8-million on R&D in Q1 2024
2023-07-28 09:58C:MDNAMedicenna Therapeutics Corp0.58SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-07-05 11:51C:MDNAMedicenna Therapeutics Corp0.65News ReleaseMedicenna receives cond. OK to extend warrants to 2024
2023-06-27 16:36C:MDNAMedicenna Therapeutics Corp0.59SEDAR Annual ReportSEDAR Annual Report
2023-06-27 16:34C:MDNAMedicenna Therapeutics Corp0.59SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2023-06-27 16:34C:MDNAMedicenna Therapeutics Corp0.59SEDAR MD & ASEDAR MD & A
2023-06-27 13:57C:MDNAMedicenna Therapeutics Corp0.59News ReleaseMedicenna cash at $33.6-million at March 31
2023-04-27 10:17C:MDNAMedicenna Therapeutics Corp0.97News ReleaseMedicenna gets extension for Nasdaq listing compliance
2023-04-17 09:59C:MDNAMedicenna Therapeutics Corp0.78News ReleaseMedicenna details IL-13 superkine data at AACR
2023-03-30 09:26C:MDNAMedicenna Therapeutics Corp0.78News ReleaseMedicenna talks further phase 1/2 Ability study data
2023-02-22 18:05C:MDNAMedicenna Therapeutics Corp0.88SEDAR Early Warning ReportSEDAR Early Warning Report
2023-02-17 17:25C:MDNAMedicenna Therapeutics Corp0.88News ReleaseMedicenna arranges $10-million (U.S.) ATM offering
2023-02-07 11:45C:MDNAMedicenna Therapeutics Corp1.00News ReleaseMedicenna Therapeutics spends $2.9M on R&D in Q3
2023-02-07 08:09C:MDNAMedicenna Therapeutics Corp1.01SEDAR MD & ASEDAR MD & A
2023-02-07 08:03C:MDNAMedicenna Therapeutics Corp1.01SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-01-26 10:42C:MDNAMedicenna Therapeutics Corp0.80News ReleaseMedicenna to hold Q3 2023 results call Feb. 7
2023-01-05 09:52C:MDNAMedicenna Therapeutics Corp0.76News ReleaseMedicenna receives U.S. patent for IL-2 superkine
2022-12-02 08:29C:MDNAMedicenna Therapeutics Corp0.79In the NewsGlobe says Buhler, others good for bargain hunters